{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:58:24Z","timestamp":1783407504917,"version":"3.54.6"},"reference-count":121,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jaip.2025.06.023","type":"journal-article","created":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T11:43:02Z","timestamp":1750765382000},"page":"1888-1899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Atopic Dermatitis With Comorbid Skin Diseases: Recognition and Successful Treatment"],"prefix":"10.1016","volume":"13","author":[{"given":"Sonam","family":"Sani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Flohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Abuabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Marie","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alphonsus","family":"Yip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelynn","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luz","family":"Fonacier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2025.06.023_bib1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jaad.2014.03.023","article-title":"Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies","volume":"71","author":"Eichenfield","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","article-title":"Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine\u2013based recommendations","volume":"132","author":"Chu","year":"2024","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/bjd.19580","article-title":"The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990\u20132017","volume":"184","author":"Laughter","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1743","article-title":"Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris","volume":"38","author":"Smith","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.jaip.2025.06.023_bib5","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/bjd.12219","article-title":"Ichthyosis vulgaris: the filaggrin mutation disease","volume":"168","author":"Thyssen","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/ski2.187","article-title":"Ichthyosis vulgaris: an updated review","volume":"3","author":"Jaffar","year":"2023","journal-title":"Skin Health Dis"},{"key":"10.1016\/j.jaip.2025.06.023_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1529-8019.2012.01555.x","article-title":"Care of the newborn with ichthyosis","volume":"26","author":"Dyer","year":"2013","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2025.06.023_bib8","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archdermatol.2011.9","article-title":"Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases","volume":"147","author":"Rajpopat","year":"2011","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib9","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/archderm.1964.01590250052010","article-title":"Netherton's disease; Trichorrhexis invaginata (bamboo hair), congenital ichthyosiform erythroderma and the atopic diathesis. a histopathologic study","volume":"89","author":"Wilkinson","year":"1964","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7527859","article-title":"Atopic dermatitis and psoriasis as overlapping syndromes","volume":"2020","author":"Bozek","year":"2020","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jaip.2025.06.023_bib11","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bjd.19265","article-title":"The challenging management of a series of 43 infants with Netherton syndrome: unexpected complications and novel mutations","volume":"184","author":"Bellon","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib12","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/pde.12220","article-title":"Netherton syndrome associated with growth hormone deficiency","volume":"31","author":"Aydin","year":"2014","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib13","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jaci.2015.04.049","article-title":"Practice parameter for the diagnosis and management of primary immunodeficiency","volume":"136","author":"Bonilla","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/pde.14401","article-title":"Diagnosing Omenn syndrome","volume":"38","author":"Cutts","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib15","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/nyas.12049","article-title":"Wiskott-Aldrich syndrome: a comprehensive review","volume":"1285","author":"Massaad","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaip.2025.06.023_bib16","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/JBM.S232650","article-title":"Hematopoietic stem cell therapy for Wiskott-Aldrich syndrome: improved outcome and quality of life","volume":"12","author":"Mallhi","year":"2021","journal-title":"J Blood Med"},{"key":"10.1016\/j.jaip.2025.06.023_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaci.2023.04.009","article-title":"The neglected twin: Nummular eczema is a variant of atopic dermatitis with codominant T(H)2\/T(H)17 immune response","volume":"152","author":"Bohner","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000018220","article-title":"Nummular eczema: an addition of senile xerosis and unique cutaneous reactivities to environmental aeroallergens","volume":"199","author":"Aoyama","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2025.06.023_bib19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1001\/archderm.141.1.102-b","article-title":"Generalized nummular eczema secondary to peginterferon Alfa-2b and ribavirin combination therapy for hepatitis C infection","volume":"141","author":"Shen","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib20","doi-asserted-by":"crossref","first-page":"R666","DOI":"10.1186\/ar1724","article-title":"Dermatological conditions during TNF-alpha-blocking therapy in patients with rheumatoid arthritis: a prospective study","volume":"7","author":"Flendrie","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaip.2025.06.023_bib21","first-page":"301","article-title":"Vulvar dermatoses: a review and update","volume":"112","author":"Simonetta","year":"2015","journal-title":"Mo Med"},{"key":"10.1016\/j.jaip.2025.06.023_bib22","series-title":"Lichen Simplex Chronicus. StatPearls. Treasure Island","author":"Charifa","year":"2025"},{"key":"10.1016\/j.jaip.2025.06.023_bib23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/09546634.2019.1708856","article-title":"A systematic review of evidence based treatments for lichen simplex chronicus","volume":"32","author":"Juarez","year":"2021","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaip.2025.06.023_bib24","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v102.4367","article-title":"Lichen simplex chronicus itch: an update","volume":"102","author":"Ju","year":"2022","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2025.06.023_bib25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-3083.2012.04481.x","article-title":"Prurigo as a symptom of atopic and non-atopic diseases: aetiological survey in a consecutive cohort of 108 patients","volume":"27","author":"Iking","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.06.023_bib26","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/01443615.2017.1329283","article-title":"Skin diseases of the vulva: eczematous diseases and contact urticaria","volume":"38","author":"Sand","year":"2018","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/j.jaip.2025.06.023_bib27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/archderm.136.6.807","article-title":"Double-blind, right\/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of prurigo nodularis","volume":"136","author":"Wong","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/tcrm.2006.2.2.213","article-title":"Treatment of pruritic diseases with topical calcineurin inhibitors","volume":"2","author":"Stander","year":"2006","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jaip.2025.06.023_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamadermatol.2018.3906","article-title":"Reduced itch associated with dupilumab treatment in 4 patients with prurigo nodularis","volume":"155","author":"Mollanazar","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib30","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.arcped.2012.05.020","article-title":"Atopic dermatitis [in French]","volume":"19","author":"Rybojad","year":"2012","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.jaip.2025.06.023_bib31","first-page":"21","article-title":"Pityriasis alba","volume":"76","author":"Lin","year":"2005","journal-title":"Cutis"},{"key":"10.1016\/j.jaip.2025.06.023_bib32","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S0091-6749(99)70050-3","article-title":"The clinical spectrum of atopic dermatitis","volume":"104","author":"Beltrani","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib33","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.12998\/wjcc.v9.i18.4681","article-title":"Clinical outcomes and 5-year follow-up results of keratosis pilaris treated by a high concentration of glycolic acid","volume":"9","author":"Tian","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jaip.2025.06.023_bib34","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.jaad.2022.12.051","article-title":"Prevalence of allergic contact dermatitis following patch testing in patients with atopic dermatitis: a retrospective United States claims-based study","volume":"88","author":"Qian","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib35","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jaci.2012.06.048","article-title":"Atopic dermatitis results in intrinsic barrier and immune abnormalities: implications for contact dermatitis","volume":"131","author":"Gittler","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib36","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jaad.2023.06.048","article-title":"Prevalence of allergic contact dermatitis in children with and without atopic dermatitis: a multicenter retrospective case-control study","volume":"89","author":"Johnson","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib37","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jaad.2016.03.010","article-title":"Inflamed skin predisposes to sensitization to less potent allergens","volume":"75","author":"Kohli","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/DER.0b013e318260d5a0","article-title":"Nummular eczema and contact allergy: a retrospective study","volume":"23","author":"Bonamonte","year":"2012","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaip.2025.06.023_bib39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/DER.0000000000000208","article-title":"A Pragmatic approach to patch testing atopic dermatitis patients: clinical recommendations based on expert consensus opinion","volume":"27","author":"Chen","year":"2016","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaip.2025.06.023_bib40","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1016\/j.jaip.2021.03.028","article-title":"Prevalence and trend of allergen sensitization in adults and children with atopic dermatitis referred for patch testing, North American Contact Dermatitis Group Data, 2001\u20132016","volume":"9","author":"Silverberg","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.023_bib41","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1001\/jamadermatol.2016.6136","article-title":"Pediatric Contact Dermatitis Registry data on contact allergy in children with atopic dermatitis","volume":"153","author":"Jacob","year":"2017","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib42","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2133.1989.tb01396.x","article-title":"Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids","volume":"121","author":"Coopman","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/DER.0000000000000726","article-title":"Patch testing during immunosuppressive therapy: a systematic review","volume":"32","author":"Mufti","year":"2021","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaip.2025.06.023_bib44","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/DER.0b013e318275969f","article-title":"Effects of immunomodulatory agents on patch testing: expert opinion 2012","volume":"23","author":"Fowler","year":"2012","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaip.2025.06.023_bib45","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jaad.2023.10.029","article-title":"Impact of dupilumab on patch test results and allergic contact dermatitis: a prospective multicenter study","volume":"90","author":"Bocquel","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/derm.2022.29011.abu","article-title":"Allergic contact dermatitis and patch testing in skin of color patients","volume":"34","author":"Burli","year":"2023","journal-title":"Dermatitis"},{"key":"10.1016\/j.jaip.2025.06.023_bib47","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2133.2005.07004.x","article-title":"Psoriasis in Swedish conscripts: time trend and association with T-helper 2\u2013mediated disorders","volume":"154","author":"Landgren","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib48","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0190-9622(95)91336-X","article-title":"Disease concomitance in psoriasis","volume":"32","author":"Henseler","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib49","first-page":"265","article-title":"Concomitance of psoriasis and atopic dermatitis","volume":"184","author":"Beer","year":"1992","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2025.06.023_bib50","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1067\/mai.2000.106484","article-title":"Atopic dermatitis: new insights and opportunities for therapeutic intervention","volume":"105","author":"Leung","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib51","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1002\/ski2.29","article-title":"Can atopic eczema and psoriasis coexist? A systematic review and meta-analysis","volume":"1","author":"Cunliffe","year":"2021","journal-title":"Skin Health Dis"},{"key":"10.1016\/j.jaip.2025.06.023_bib52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.0022-0477.2001.01250.x","article-title":"Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data","volume":"32","author":"Simpson","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.06.023_bib53","first-page":"139","article-title":"Can atopic dermatitis and allergic contact dermatitis coexist?","volume":"110","author":"Johnson","year":"2022","journal-title":"Cutis"},{"key":"10.1016\/j.jaip.2025.06.023_bib54","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15814","article-title":"New onset atopic dermatitis and psoriasis in the same patients under biologic treatments: the role of systemic treatments as a possible trigger","volume":"35","author":"Paolino","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaip.2025.06.023_bib55","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1111\/jdv.15213","article-title":"Psoriasis dermatitis: an overlap condition of psoriasis and atopic dermatitis in children","volume":"33","author":"Kouwenhoven","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.06.023_bib56","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.3390\/ijms23105518","article-title":"Overlapping features of psoriasis and atopic dermatitis: from genetics to immunopathogenesis to phenotypes","volume":"23","author":"Tsai","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaip.2025.06.023_bib57","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jaad.2014.03.030","article-title":"Guidelines of care for the management of atopic dermatitis: section 3. Management and treatment with phototherapy and systemic agents","volume":"71","author":"Sidbury","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib58","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaad.2019.04.042","article-title":"Joint American Academy of Dermatology\u2013National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy","volume":"81","author":"Elmets","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jaad.2024.03.007","article-title":"Use of dual biologic therapy targeting the Th2 and Th17 axes simultaneously to treat patients with atopic dermatitis and concomitant psoriasis, psoriatic arthritis, or inflammatory bowel disease","volume":"91","author":"Hren","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib60","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.12788\/cutis.0858","article-title":"Concurrent atopic dermatitis and psoriasis successfully treated with dual biologic therapy","volume":"112","author":"Kaszycki","year":"2023","journal-title":"Cutis"},{"key":"10.1016\/j.jaip.2025.06.023_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19044","article-title":"Association between alopecia areata and atopic dermatitis: current evidence","author":"Chen","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.06.023_bib62","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/cea.13729","article-title":"Bidirectional association between alopecia areata and atopic dermatitis: a population-based cohort study in Taiwan","volume":"50","author":"Wei","year":"2020","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.06.023_bib63","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jaip.2020.01.052","article-title":"Alopecia areata is associated with atopic diathesis: results from a population-based study of 51,561 patients","volume":"8","author":"Kridin","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.023_bib64","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1111\/jdv.16727","article-title":"Comorbidities in pediatric alopecia areata","volume":"34","author":"Conic","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.06.023_bib65","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/bjd\/ljae385","article-title":"British Association of Dermatologists living guideline for managing people with alopecia areata 2024","volume":"192","author":"Harries","year":"2025","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib66","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2016.12.005","article-title":"JAK inhibitors in dermatology: the promise of a new drug class","volume":"76","author":"Damsky","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib67","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.jaad.2022.01.009","article-title":"American Academy of Dermatology Guidelines: awareness of comorbidities associated with atopic dermatitis in adults","volume":"86","author":"Davis","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib68","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s40265-020-01293-0","article-title":"New and emerging therapies for alopecia areata","volume":"80","author":"Pourang","year":"2020","journal-title":"Drugs"},{"key":"10.1016\/j.jaip.2025.06.023_bib69","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2019.06.010","article-title":"Cause or cure? Review of dupilumab and alopecia areata","volume":"88","author":"Marks","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib70","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2016.08.047","article-title":"Autoimmune diseases in adults with atopic dermatitis","volume":"76","author":"Andersen","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib71","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1007\/s12325-024-02875-0","article-title":"Epidemiology and treatment patterns of patients with vitiligo: a real-world analysis","volume":"41","author":"Ramot","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaip.2025.06.023_bib72","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40257-022-00752-6","article-title":"Vitiligo treatments: review of current therapeutic modalities and JAK inhibitors","volume":"24","author":"Cunningham","year":"2023","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib73","doi-asserted-by":"crossref","DOI":"10.1177\/15593258221105370","article-title":"Baricitinib is effective in treating progressing vitiligo in vivo and in vitro","volume":"20","author":"Dong","year":"2022","journal-title":"Dose Response"},{"key":"10.1016\/j.jaip.2025.06.023_bib74","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/ajd.13348","article-title":"Repigmentation of vitiligo with oral baricitinib","volume":"61","author":"Mumford","year":"2020","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib75","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jaci.2024.01.028","article-title":"Dupilumab in patients with chronic spontaneous urticaria (LIBERTY-CSU CUPID): two randomized, double-blind, placebo-controlled, phase 3 trials","volume":"154","author":"Maurer","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib76","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.jaci.2013.08.012","article-title":"Childhood atopic dermatitis and warts are associated with increased risk of infection: a US population-based study","volume":"133","author":"Silverberg","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib77","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/S0190-9622(03)00896-X","article-title":"Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases","volume":"49","author":"Wollenberg","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib78","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s12016-016-8548-5","article-title":"Bacterial and viral infections in atopic dermatitis: a comprehensive review","volume":"51","author":"Ong","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib79","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jaci.2012.06.019","article-title":"Staphylococcus aureus \u03b1-toxin modulates skin host response to viral infection","volume":"130","author":"Bin","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib80","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jid.2017.01.030","article-title":"Increased risk of cutaneous and systemic infections in atopic dermatitis\u2014a cohort study","volume":"137","author":"Langan","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib81","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/jid.2014.43","article-title":"Th2 cytokines increase Staphylococcus aureus alpha toxin\u2013induced keratinocyte death through the signal transducer and activator of transcription 6 (STAT6)","volume":"134","author":"Brauweiler","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib82","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1101\/gr.131029.111","article-title":"Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis","volume":"22","author":"Kong","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.jaip.2025.06.023_bib83","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jaip.2023.03.041","article-title":"Managing atopic dermatitis in patients with skin of color","volume":"11","author":"Davis","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.023_bib84","doi-asserted-by":"crossref","DOI":"10.1128\/mSphere.00295-16","article-title":"Temporal and racial differences associated with atopic dermatitis Staphylococcus aureus and encoded virulence factors","volume":"1","author":"Merriman","year":"2016","journal-title":"mSphere"},{"key":"10.1016\/j.jaip.2025.06.023_bib85","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.intimp.2017.11.031","article-title":"Adverse events of dupilumab in adults with moderate-to-severe atopic dermatitis: a meta-analysis","volume":"54","author":"Ou","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jaip.2025.06.023_bib86","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaci.2011.02.043","article-title":"Malassezia sympodialis thioredoxin\u2013specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis","volume":"128","author":"Balaji","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib87","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s13671-015-0123-4","article-title":"The role of yeast in atopic dermatitis revisited: a critical appraisal","volume":"4","author":"Tsakok","year":"2015","journal-title":"Curr Dermatol Rep"},{"key":"10.1016\/j.jaip.2025.06.023_bib88","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2133.2001.04082.x","article-title":"Seborrhoeic dermatitis and Pityrosporum (Malassezia) folliculitis: characterization of inflammatory cells and mediators in the skin by immunohistochemistry","volume":"144","author":"Faergemann","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib89","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.clindermatol.2013.01.001","article-title":"Seborrheic dermatitis: etiology, risk factors, and treatments: facts and controversies","volume":"31","author":"Dessinioti","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib90","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/09546634.2018.1473554","article-title":"Treatment of seborrheic dermatitis: a comprehensive review","volume":"30","author":"Borda","year":"2019","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaip.2025.06.023_bib91","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF02434889","article-title":"Yeast fungi in patients with allergic diseases: species variety and sensitivity to antifungal drugs","volume":"129","author":"Arzumanyan","year":"2000","journal-title":"Bull Exp Biol Med"},{"key":"10.1016\/j.jaip.2025.06.023_bib92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.revmed.2016.05.022","article-title":"Main parasitic skin disorders [in French]","volume":"38","author":"Bernigaud","year":"2017","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.jaip.2025.06.023_bib93","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1111\/bjd.18643","article-title":"The role of bacterial skin infections in atopic dermatitis: expert statement and review from the International Eczema Council Skin Infection Group","volume":"182","author":"Alexander","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib94","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/all.15010","article-title":"Evolution and long-term outcomes of combined immunodeficiency due to CARMIL2 deficiency","volume":"77","author":"Kolukisa","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2025.06.023_bib95","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/pai.13236","article-title":"Clinical, immunological features and follow up of 20 patients with dedicator of cytokinesis 8 (DOCK8) deficiency","volume":"31","author":"Haskologlu","year":"2020","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib96","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jaci.2018.08.013","article-title":"Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease","volume":"143","author":"Dorjbal","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib97","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/jamadermatol.2019.3786","article-title":"Noncutaneous and cutaneous cancer risk in patients with atopic dermatitis: a systematic review and meta-analysis","volume":"156","author":"Wang","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib98","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/sj.jid.5700622","article-title":"Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis","volume":"127","author":"Arellano","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib99","first-page":"778","article-title":"The risk of malignancy associated with psoriasis","volume":"137","author":"Margolis","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib100","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.jaci.2009.02.028","article-title":"Lymphoma among patients with atopic dermatitis and\/or treated with topical immunosuppressants in the United Kingdom","volume":"123","author":"Arellano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib101","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/bjd\/ljad072","article-title":"Malignancy risk in patients with atopic dermatitis: a population-based cohort study","volume":"189","author":"Wan","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib102","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.jaci.2025.02.002","article-title":"Is dupilumab use in atopic dermatitis associated with cutaneous T-cell lymphoma?","volume":"155","author":"Ong","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib103","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.hoc.2018.09.001","article-title":"Mycosis fungoides and Sezary syndrome: an update","volume":"33","author":"Larocca","year":"2019","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaip.2025.06.023_bib104","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41572-021-00296-9","article-title":"Cutaneous T cell lymphoma","volume":"7","author":"Dummer","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jaip.2025.06.023_bib105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1067\/mjd.2002.121355","article-title":"Practical evaluation and management of cutaneous lymphoma","volume":"46","author":"Fung","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib106","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2340\/00015555-3208","article-title":"Diagnosis of mycosis fungoides following administration of dupilumab for misdiagnosed atopic dermatitis","volume":"99","author":"Chiba","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaip.2025.06.023_bib107","doi-asserted-by":"crossref","first-page":"e305","DOI":"10.1016\/j.jaad.2023.01.047","article-title":"Unmasking a masquerader: mycosis fungoides unveiled after dupilumab treatment","volume":"88","author":"Joshi","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib108","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.1111\/ijd.16641","article-title":"Diagnosing mycosis fungoides after initiation of therapy with dupilumab: a case report and literature review","volume":"62","author":"Yan","year":"2023","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib109","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1684\/ejd.2023.4554","article-title":"Acceleration of cutaneous T-cell lymphoma mistaken for atopic dermatitis following JAK inhibitor use","volume":"33","author":"Lamolet","year":"2023","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaip.2025.06.023_bib110","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdcr.2024.07.031","article-title":"Upadacitinib unmasks cutaneous T-cell lymphoma in atopic dermatitis","volume":"52","author":"Bui","year":"2024","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.jaip.2025.06.023_bib111","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.jaci.2024.10.028","article-title":"Integrative epidemiology and immunotranscriptomics uncover a risk and potential mechanism for cutaneous lymphoma unmasking or progression with dupilumab therapy","volume":"155","author":"Cabrera-Perez","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib112","doi-asserted-by":"crossref","DOI":"10.1111\/jdv.19112","article-title":"Cutaneous manifestations induced by check point inhibitors in 120 melanoma patients\u2014the European MelSkinTox study","author":"L'Orphelin","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaip.2025.06.023_bib113","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.965550","article-title":"Incidence and factors associated with cutaneous immune-related adverse events to immune check point inhibitors: an ambispective cohort study","volume":"13","author":"Luangnara","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib114","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jaci.2012.02.036","article-title":"Update on risk factors for food allergy","volume":"129","author":"Lack","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/jcm10020233","article-title":"Filaggrin loss-of-function mutations are risk factors for severe food allergy in children with atopic dermatitis","volume":"10","author":"Astolfi","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaip.2025.06.023_bib116","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2222.2005.02260.x","article-title":"Epicutaneous exposure to peanut protein prevents oral tolerance and enhances allergic sensitization","volume":"35","author":"Strid","year":"2005","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2025.06.023_bib117","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00130832-200410000-00009","article-title":"Role of food allergy in atopic dermatitis","volume":"4","author":"Werfel","year":"2004","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib118","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.anai.2016.01.022","article-title":"Association of food allergy and atopic dermatitis exacerbations","volume":"116","author":"Roerdink","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2025.06.023_bib119","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1016\/j.jaip.2022.06.044","article-title":"Dietary elimination for the treatment of atopic dermatitis: a systematic review and meta-analysis","volume":"10","author":"Oykhman","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2025.06.023_bib120","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJMcp1104084","article-title":"Hand eczema","volume":"367","author":"Coenraads","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2025.06.023_bib121","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jdv.16061","article-title":"Hand eczema: epidemiology, prognosis and prevention","volume":"34","author":"Agner","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982500604X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221321982500604X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:53:37Z","timestamp":1778853217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221321982500604X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":121,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S221321982500604X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2025.06.023","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atopic Dermatitis With Comorbid Skin Diseases: Recognition and Successful Treatment","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2025.06.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}